Illumina Inc (ILMN)

Industry Diagnostics & Research

This stock can be held in an Investment ISA and an Investment Account

Sell

$133.22

Buy

$135.14

arrow-up$0.05 (+0.04%)

Prices updated at 15 Dec 2025, 13:54 EST

Prices minimum 15 mins delay

Prices in USD

Illumina Inc engages in life science tools and machines for analyzing genetic material. The company primarily engages in microarray and genome sequencing machines and disposables. It also provides sequencing services through its products.

NASDAQ

-0.59%

NASDAQ

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

Income statement

Year chevron-l-regular chevron-r-regular	2023	2024
	4,504m	4,372m
	2,744m	2,861m
	-222m	600m
	-4.93	13.72
	-1,161m	-1,223m
	-608m	-725m
Sales, General and administrative	1,612m	1,092m
Interest expenses	77m	100m
Provision for income taxes	44m	44m
Operating expenses	2,966m	2,261m
Income before taxes	-1,117m	-1,179m
Net income available to common shareholders	-1,161m	-1,223m
	-7.34	-7.69
Net interest income	-19m	-54m
Advertising and promotion	-	-
Net investment income, net	-	-
Realised capital gains (losses), net	-	-
Total benefits, claims and expenses	-	-
Earnings per share (diluted)	-7.34	-7.69
Free cash flow per share	1.065	3.4394
Book value/share	37.0943	13.3648
Debt equity ratio	0.378764	0.861357

Balance sheet

Year chevron-l-regular chevron-r-regular	2023	2024
Current assets	2,609m	2,746m
Current liabilities	1,570m	1,547m
Total capital	7,234m	3,863m
Total debt	2,262m	2,622m
Total equity	5,745m	2,373m
Total non current liabilities	-	-
Loans	1,489m	1,490m
Total assets	10,111m	6,303m
Total liabilities	-	-
Cash and cash equivalents	1,048m	1,127m
Common stock	159m	159m

Cash flow

Year chevron-l-regular chevron-r-regular	2023	2024
Cash at beginning of period	2,011m	1,048m
Cash dividends paid	-	-
	282m	709m
Investments (gains) losses	-231m	-178m
	1,048m	1,127m
Net income	-	-
	478m	837m
	-196m	-128m

The figures shown in the tables are quoted in the currency of the stock selected.

Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.